He will give Dean’s Distinguished Lecture in the Clinical Sciences Jan. 15
Donald Landry ’75 has been chosen to give the Dean’s Distinguished Lecture in the Clinical Sciences by Columbia University Medical Center. He will speak on “Vasodilatory Shock: Bedside to Bench, and Back” 4:30 p.m. Tuesday, Jan. 15, at P&S Alumni Auditorium, 650 West 168th Street, first floor. A reception will follow.
Landry is professor of medicine, director of the division of experimental therapeutics, director of the division of nephrology, and interim chair of the department of medicine at Columbia University.
- He is featured in “Landry ’75 Creates Artificial Enzyme to Block Cocaine” on the alumni web site.
Joseph Sherma, Larkin Professor Emeritus of Chemistry, plans to attend the talk.
“Don has been a good friend of the College and chemistry department, returning to campus since his graduation many times to participate in classes, give seminars to students on his research, and meet with students about applying to and performing successfully in graduate and medical school,” he says. “He has also mentored at least one student in the College’s LEARN Program, and participated in one of our spring honors convocations as I recall. He was gracious enough to travel to California to present a talk at a symposium related to my 1995 American Chemical Society Award for Research at an Undergraduate Institution, sponsored by Research Corporation.
“He met at Columbia a couple of months ago with Danielle Martin, a 2006 B.S. biochemistry graduate who did research with (Krieder Professor Emeritus of Biology) Bernie (Fried) and me, entered a Ph.D. program at Yale, and now is applying to medical school, to help her with her medical school applications and especially aid her in getting into Columbia.”
Landry completed his Ph.D. in organic chemistry under Nobel laureate Robert Burns Woodward at Harvard in 1979 and earned an M.D. from Columbia University in 1983. After residency in internal medicine at Massachusetts General Hospital, he returned to Columbia as an NIH Physician-Scientist from 1985-90. In 1991, he established his laboratory at Columbia to investigate medical applications of artificial enzymes. He founded the division of experimental therapeutics in 1998 and became chief of nephrology in 2003. His research focuses on novel therapeutics for intractable problems such as cocaine addiction and nerve gas intoxication. Clinically, he specializes in the care of critically ill patients.